Bayer Pharmaceuticals

Johnson & Johnson, Bayer win second trial over Xarelto bleeding risks

By Glenn Minnis | Wednesday, Jun 14, 2017 @ 7:41am

&&&A federal jury in New Orleans has cleared Johnson & Johnson and Bayer AG in the second of at least 18,600 suits filed against the pharmaceutical giants stemming from the manufacturing of the blood-thinning drug Xarelto.
Johnson & Johnson, Bayer prevail in first of 18,000 Xarelto trials

By Glenn Minnis | Wednesday, May 17, 2017 @ 7:51pm

After emerging victorious in the first of more than 18,000 suits filed against them, Xarelto maker Johnson & Johnson and Bayer Pharmaceuticals are vowing to remain as vigilant as ever in defending their reputations.